[1]余 震,柳 洲.消瘤方对子宫内膜异位症大鼠盆腔粘连的影响[J].陕西中医,2022,(1):13-16.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.003]
　YU Zhen,LIU Zhou.Effect and the mechanism of Xiaoliu decoction on pelvic adhesion in rats with endometriosis[J].,2022,(1):13-16.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.003]
点击复制

消瘤方对子宫内膜异位症大鼠盆腔粘连的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年1期
页码:
13-16
栏目:
基础研究
出版日期:
2022-01-05

文章信息/Info

Title:
Effect and the mechanism of Xiaoliu decoction on pelvic adhesion in rats with endometriosis
作者:
余 震1; 柳 洲1; 2
(1.贵州医科大学,贵州 贵阳550004; 2.上海市浦东新区周浦医院妇产科,上海201318)
Author(s):
YU Zhen; LIU Zhou
(Guizhou Medicine University, Guiyang 550004,China)
关键词:
子宫内膜异位症;  盆腔粘连;  消瘤方;  炎性因子;  黏附因子;  大鼠
Keywords:
Endometriosis;  Pelvic adhesion;  Xiaoliu decoction;  Inflammation factors;  Adhesion factors;  Rats
分类号:
R 711.71
DOI:
DOI:10.3969/j.issn.1000-7369.2022.01.003
文献标志码:
A
摘要:
目的:探讨消瘤方对子宫内膜异位症大鼠模型盆腔粘连的影响及机制。方法:采用自体移植构建盆腔子宫内膜异位症大鼠模型,分别使用不同剂量的消瘤方提取物[1.89、3.78 g/(kg·d)],米非司酮混悬液及0.9%氯化钠溶液连续灌胃4周后剖腹探查。采用美国生殖医学会粘连分级(AFS)、Haber评分法对盆腔粘连情况进行评估,酶联吸附(ELISA)法检测大鼠血清中白介素-6、白介素-15、白介素-18、粘连组织组织型纤溶酶原激活剂(tPA)活性,免疫组化法检测血管内皮生长因子(VEGF)、肿瘤坏死因子α(TNF-α)、细胞间黏附分子1(ICAM1)表达水平、微血管密度计数(MVD)。结果:与空白对照组相比,米非司酮和消瘤方处理大鼠后的盆腔粘连评分明显降低,血清中IL-6、IL-15、VEGT、TNF-α、ICAM1等表达水平均明显降低,血清中IL-18、粘连组织tPA活性均升高(P<0.05),异位内膜组织VEGF、TNF-α、ICAM1蛋白表达水平、微血管密度计数均显著降低(P<0.05); 与低剂量消瘤方组[1.89 g/(kg·d)]相比,高剂量消瘤方组[3.78 g/(kg·d)]和米非司酮组,盆腔粘连评分高,异位病灶生长好,血清各细胞因子水平表达均降低,IL-18、异位内膜组织VEGF、TNF-α、ICAM1蛋白表达、tPA活性高(P<0.05); 高剂量消瘤方组和米非司酮组在病灶生长情况、盆腔粘连评分、血清各细胞因子水平及异位组织蛋白表达无统计学差异(P>0.05)。结论:消瘤方能明显减轻盆腔炎症环境,抑制内异症病灶生长、改善盆腔粘连。
Abstract:
Objective:To explore the effect and mechanism of Chinese medicine Xiaoliu decoction on pelvic adhesion in rats with endometriosis.Methods:Pelvic endometriosis rats with auto-transplantation successfully were deal with different doses of Xiaoliu decoction[1.89,3.78 g/(kg·d)],mifepristone suspension and 0.9% NaCl solution,continuous intragastric for 4 weeks and then laparotomy was performed.The pelvic adhesion was evaluated by the American Society for Reproductive Medicine Classification of Endometriosis(AFS)and Haber adhesion score.Serum Interleukin-6、serum Interleukin-15、serum Interleukin-18(IL-6,IL-15,IL-18)、vascular endothelial growth factor(VEGF),tumor necrosis factor-a(TNF-α),intercellular adhesion molecule-1(ICAM1),the actives of tissue- type plasminogen activator(tPA)of adhesion tissues were detected by enzyme-linked adsorption(ELISA),the protein expression of VEGF,TNF-α,ICAM1 and microvessel density(MVD)were measured by immunohistochemistry.Results:Compared with blank control group,the pelvic score of rats treated with mifepristone and Xiaoliu decoction were significantly decreased,and expression of IL-6,IL-15,VEGF,TNF-α,ICAM1 of serum were significantly decreased,the levels of IL-18 of serum、the activity of tPA in adhesion were higher(P<0.05),the levels of protein expression of VEGF,TNF-α,ICAM1,and the microvessel density count were significantly decreased(P<0.05).Compared with high-dose Xiaoliu decoction group [3.78 g/(kg·d)]and mifepristone group,the low-dose Xiaoliu decoction group[1.89 g/(kg·d)]had better growth of ectopic lesions,higher pelvic adhesion score,higher levels of serum cytokines,lower level of serum IL-18 and protein expressions of VEGF,TNF-α,ICAM1 and tPA activity in the ectopic intima tissues(P<0.05)。While there was no obviously difference between high- dosage Xiaoliu decoction group and mifepristone group in ectopic lesion growth,pelvic adhesion score、levels of serum cytokines and ectopic tissues protein expression(P>0.05)。Conclusion:Xiaoliu decoction can significantly relieve the inflammatory environment of pelvic,inhibit the growth of internal abnormal lesions and improve pelvic adhesion.

参考文献/References:

[1] 冷金花,郎景和,杨佳欣.子宫内膜异位症的诊治进展[J].中国妇产科杂志,2000,35(1):53-54.
[2] Emre SAA.Endometriosis:Interaction of immune and endocrine systems[J].Seminars in Reproductive Medicine,2003,21(2):135-144.
[3] Kralickova M,Fiala L,Losan P,et al.Altered immunity in endometriosis:What came first?[J].Immunol Invest,2018,47(6):569-582.
[4] Olovsson M.Immunological aspects of endometriosis:An update[J].Am J Reprod Immunol,2011,66(1):101-104.
[5] 周 华,张 倩,杨碧蓉,等.消瘤方对子宫内膜异位症患者子宫内膜细胞增殖及凋亡的影响[J].现代中医临床,2019,26(2):52-55.77.
[6] 周 华,齐 聪.补肾活血方对大鼠子宫内膜细胞病理形态学及凋亡的影响[J].上海中医药大学学报,2012,26(6):96-99.
[7] Ahn SH,Monsanto SP,Miller C,et al.Pathophysiology and immune dysfunction in endometriosis[J].Biomed Res Int,2015,7(12):1-12.
[8] 刘朵朵.子宫内膜异位症患者腹腔液及血清VEGF、TNF测定临床意义[J].陕西医学杂志,2010,39(4):448-450.
[9] Crispim PCA,Jammal MP,Murta EFC,et al.Endometriosis:What is the influence of immune cells?[J].Immunol Invest,2020,50(4):372-388.
[10] Othman E,Hornung D,Salem HT,et al.Serum cytokines as biomarkers for nonsurgical prediction of endometriosis[J].Eur J Obstet Gynecol Reprod Biol,2008,137(2):240-246.
[11] 苏庆红,王 岚,葛莉宾,等.盆腔子宫内膜异位症粘连与疼痛的关系[J].中国妇幼保健,2017,32(23):5833-5835.
[12] Herington JL,Bruner-Tran KL,Lucas JA,et al.Immune interactions in endometriosis[J].Expert Rev Clin Immunol,2011,7(5):611-626.
[13] Malvezzi H,Hernandes C,Piccinato CA,et al.Interleukin in endometriosis-associated infertility-pelvic pain:Systematic review and Meta-analysis[J].Reproduction,2019,158(1):1-12.
[14] 梁 塽,杨晓葵,张 颖.免疫功能异常在子宫内膜异位症内膜容受性中研究进展[J].国际妇产科学杂志,2020,47(6):689-693.
[15] 李晓红,吴晓雄,达万明,等.IL-2、IL-15对NK细胞KIR3DL1、NKG2D表达的影响[J].军医进修学院学报,2011,32(6):622-624.
[16] 殷向平.IL-18在子宫内膜异位症中的临床研究[J].中国实用医药,2012,7(5):48-49.
[17] 谷杭芝,张 徐,王光演,等.血管内皮生长因子基因多态性与子宫内膜异位症的相关性[J].温州医科大学学报,2020,50(5):391-394.
[18] 姜伶俐,王 鹰,柳 洲,等.子宫内膜异位症中黏附分子VCAM-1和ICAM-1的表达及作用[J].临床和实验医学杂志,2019,18(1):51-55.
[19] Kuessel L,Wenzl R,Proestling K,et al.Soluble VCAM-1,soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis[J].Hum Reprod,2017,32(4):770-779.
[20] 李 潇,周艳艳.补肾活血方对肾虚血瘀型子宫内膜异位症不孕患者子宫内膜容受性的影响[J].陕西中医,2018,39(3):341-344.

相似文献/References:

[1]胡贞君,刘笑梅△,曹保利.复方莪术散治疗子宫内膜异位症疗效及其分子学研究进展*[J].陕西中医,2019,(9):1315.
[2]张 莉,金 晶,季 菲△.丹莪妇康煎膏联合孕三烯酮治疗子宫内膜异位症疗效及对患者CA125、TNF-α和IL-6水平的影响*[J].陕西中医,2020,(10):1370.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.007]
[3]李承秋,吕文艺,金 凡,等.活血消异汤联合米非司酮对子宫内膜异位症患者血清MMP-3、CA125、EMAb水平的影响[J].陕西中医,2021,(3):297.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.006]
　LI Chengqiu,LV Wenyi,JIN Fan,et al.Effect of Huoxue Xiaoyi decoction combined with mifepristone on the serum levels of MMP-3,CA125 and EMAb in patients with endometriosis[J].,2021,(1):297.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.006]
[4]陈亚杰,闻 姬.子宫内膜异位症中西医认识及治疗研究进展[J].陕西中医,2021,(10):1486.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.043]
[5]董秀娟,曹若愚,于洪基,等.大蒜素对子宫内膜异位症大鼠异位病灶及缺氧诱导因子-1α表达的影响[J].陕西中医,2022,(4):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
　DONG Xiujuan,CAO Ruoyu,YU Hongji,et al.Effects of Allicin on the ectopic lesions and the expression of HIF-1α in rats with endometriosis[J].,2022,(1):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
[6]赵 娜,周灵雪,杨向荣.桂枝茯苓胶囊联合戈舍瑞林对子宫内膜异位症患者子宫动脉血流动力学及Th1/Th2细胞因子的影响[J].陕西中医,2022,(4):446.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.008]
　ZHAO Na,ZHOU Lingxue,YANG Xiangrong.Effects of Guizhi Fuling capsule combined with goserelin on uterine artery hemodynamics and Th1/Th2 cytokines in endometriosis patients[J].,2022,(1):446.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.008]
[7]刘 叶,赵亚芹.活血通络解毒汤治疗子宫内膜异位症疗效及对患者卵巢功能的影响[J].陕西中医,2022,(4):450.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.009]
　LIU Ye,ZHAO Yaqin.Therapeutic effect of Huoxue Tongluo Jiedu decoction on endometriosis and its influence on ovarian function of patients[J].,2022,(1):450.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.009]
[8]宋梦杨,连 方.连方教授治疗子宫内膜异位症经验[J].陕西中医,2022,(4):511.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.026]
　SONG Mengyang,LIAN Fang.LIAN Fang's experience in treating endometriosis with Quyu Jiedu decoction[J].,2022,(1):511.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.026]
[9]杨润雨,陈 瑶,冯晓玲.中医药治疗子宫内膜异位症致不孕研究进展[J].陕西中医,2023,(5):670.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.032]
　YANG Runyu,CHEN Yao,FENG Xiaoling.Research progress of traditional Chinese medicine in the treatment of infertility caused by endometriosis[J].,2023,(1):670.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.032]
[10]赵佳琪,刘凯莉,李昱帅,等.子宫内膜异位症相关通路及中医药干预研究进展[J].陕西中医,2023,(9):1316.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.038]
　ZHAO Jiaqi,LIU Kaili,LI Yushuai,et al.Research progress on the related pathways of endometriosis and the intervention of traditional Chinese medicine[J].,2023,(1):1316.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.038]

备注/Memo

备注/Memo:
基金项目:上海市浦东新区科技发展基金资助项目(PKJ2020-Y46)
更新日期/Last Update: 2022-01-09